Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Sanofi (SNY) Equity Ratio (2016 - 2025)

Sanofi (SNY) has disclosed Equity Ratio for 9 consecutive years, with 0.56 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 3.56% to 0.56 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15 through Dec 2025, down 26.37% year-over-year, with the annual reading at 0.56 for FY2025, 3.56% down from the prior year.
  • Equity Ratio hit 0.56 in Q4 2025 for Sanofi, down from 0.58 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.59 in Q4 2022 to a low of 0.56 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.58 across 4 years, with a median of 0.58 in 2023.
  • Biggest five-year swings in Equity Ratio: fell 0.31% in 2024 and later decreased 3.56% in 2025.
  • Year by year, Equity Ratio stood at 0.59 in 2022, then fell by 0.79% to 0.59 in 2023, then dropped by 0.31% to 0.58 in 2024, then dropped by 3.56% to 0.56 in 2025.
  • Business Quant data shows Equity Ratio for SNY at 0.56 in Q4 2025, 0.58 in Q4 2024, and 0.59 in Q4 2023.